Adam Clammer has an estimated net worth of $2.49 Billion. This is based on reported shares across multiple companies, which include JAZZ PHARMACEUTICALS INC, Avago Technologies LTD, Bilander Acquisition Corp., EASTMAN KODAK CO, ROVER GROUP, INC., ZHONE TECHNOLOGIES INC, Open Lending Corp, Nebula Acquisition Corp, TWC Tech Holdings II Corp., AEP INDUSTRIES INC, ALLIANCE IMAGING INC /DE/, MEDCATH CORP, ZIX CORP, ZTI MERGER SUBSIDIARY III INC, Techpoint, Inc., and Cellebrite DI Ltd..
2004 was Adam Clammer's most active year for acquiring shares with 7 total transactions. Adam Clammer's most active month to acquire stocks was the month of November. 2021 was Adam Clammer's most active year for disposing of shares, totalling 7 transactions. Adam Clammer's most active month to dispose stocks was the month of December. 2021 saw Adam Clammer paying a total of $83,861,246.00 for 52,110,791 shares, this is the most they've acquired in one year. In 2021 Adam Clammer cashed out on 57,525,207 shares for a total of $177,225,008.50, their largest year based on trade value.